LITHIUM BROMATUM

N/A

Manufactured by Advagen Pharma Ltd

52,863 FDA adverse event reports analyzed

Last updated: 2026-04-14

About LITHIUM BROMATUM

LITHIUM BROMATUM is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Advagen Pharma Ltd. The most commonly reported adverse reactions for LITHIUM BROMATUM include DRUG INEFFECTIVE, TOXICITY TO VARIOUS AGENTS, OFF LABEL USE, DRUG INTERACTION, TREMOR. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for LITHIUM BROMATUM.

Top Adverse Reactions

DRUG INEFFECTIVE2,243 reports
TOXICITY TO VARIOUS AGENTS2,179 reports
OFF LABEL USE1,549 reports
DRUG INTERACTION1,527 reports
TREMOR1,464 reports
NAUSEA1,343 reports
WEIGHT INCREASED1,153 reports
FATIGUE1,067 reports
VOMITING1,016 reports
DEPRESSION986 reports
ANXIETY961 reports
SOMNOLENCE914 reports
INSOMNIA898 reports
SUICIDAL IDEATION891 reports
DIZZINESS818 reports
CONFUSIONAL STATE801 reports
CONDITION AGGRAVATED795 reports
DIARRHOEA769 reports
MANIA755 reports
COMPLETED SUICIDE713 reports
HEADACHE713 reports
OVERDOSE707 reports
PSYCHOTIC DISORDER638 reports
SUICIDE ATTEMPT629 reports
NEUROLEPTIC MALIGNANT SYNDROME608 reports
ASTHENIA607 reports
FEELING ABNORMAL600 reports
ACUTE KIDNEY INJURY599 reports
AGITATION579 reports
PRODUCT USE IN UNAPPROVED INDICATION574 reports
PNEUMONIA566 reports
MALAISE562 reports
FALL538 reports
SCHIZOPHRENIA519 reports
DYSPNOEA508 reports
PAIN483 reports
SEDATION470 reports
HYPERTENSION469 reports
MEMORY IMPAIRMENT463 reports
GAIT DISTURBANCE457 reports
WEIGHT DECREASED454 reports
PYREXIA434 reports
NEUTROPENIA432 reports
IRRITABILITY431 reports
BIPOLAR DISORDER411 reports
SEROTONIN SYNDROME407 reports
CONSTIPATION402 reports
AGGRESSION396 reports
EXTRAPYRAMIDAL DISORDER395 reports
INTENTIONAL OVERDOSE377 reports
HYPERHIDROSIS372 reports
DIABETES MELLITUS371 reports
AKATHISIA368 reports
HYPOTENSION352 reports
RASH349 reports
SEIZURE342 reports
DYSARTHRIA332 reports
DYSKINESIA326 reports
DEATH325 reports
MENTAL DISORDER322 reports
TREATMENT NONCOMPLIANCE322 reports
TACHYCARDIA314 reports
COGNITIVE DISORDER312 reports
DELIRIUM312 reports
LEUKOPENIA310 reports
RENAL FAILURE309 reports
HYPOMANIA308 reports
LOSS OF CONSCIOUSNESS308 reports
HALLUCINATION307 reports
VISION BLURRED306 reports
ARTHRALGIA298 reports
HALLUCINATION, AUDITORY298 reports
BALANCE DISORDER297 reports
DISTURBANCE IN ATTENTION295 reports
ABNORMAL BEHAVIOUR294 reports
NEPHROGENIC DIABETES INSIPIDUS294 reports
DEHYDRATION289 reports
ABDOMINAL PAIN281 reports
PARKINSONISM280 reports
TARDIVE DYSKINESIA280 reports
DISORIENTATION275 reports
DRUG ABUSE274 reports
URINARY TRACT INFECTION274 reports
RESTLESSNESS273 reports
LETHARGY264 reports
ELECTROCARDIOGRAM QT PROLONGED262 reports
PAIN IN EXTREMITY262 reports
DECREASED APPETITE258 reports
ATAXIA257 reports
OBSESSIVE COMPULSIVE DISORDER257 reports
FOETAL EXPOSURE DURING PREGNANCY254 reports
CHEST PAIN253 reports
SPEECH DISORDER253 reports
HEPATIC ENZYME INCREASED252 reports
CHOLELITHIASIS247 reports
CHRONIC KIDNEY DISEASE245 reports
DRUG DOSE OMISSION244 reports
HOSPITALISATION240 reports
WITHDRAWAL SYNDROME239 reports
SLEEP DISORDER237 reports

Report Outcomes

Out of 24,361 classified reports for LITHIUM BROMATUM:

Serious 77.6%Non-Serious 22.4%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female12,863 (57.8%)
Male9,269 (41.6%)
Unknown127 (0.6%)

Reports by Age

Age 52571 reports
Age 59398 reports
Age 60380 reports
Age 54372 reports
Age 42364 reports
Age 40363 reports
Age 50361 reports
Age 55359 reports
Age 45358 reports
Age 56357 reports
Age 53345 reports
Age 51334 reports
Age 35323 reports
Age 30320 reports
Age 47320 reports
Age 49318 reports
Age 44315 reports
Age 66312 reports
Age 57304 reports
Age 48301 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with LITHIUM BROMATUM?

This profile reflects 52,863 FDA FAERS reports that mention LITHIUM BROMATUM. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for LITHIUM BROMATUM?

Frequently reported terms in FAERS include DRUG INEFFECTIVE, TOXICITY TO VARIOUS AGENTS, OFF LABEL USE, DRUG INTERACTION, TREMOR, NAUSEA. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures LITHIUM BROMATUM?

Labeling and FAERS entries often list Advagen Pharma Ltd in connection with LITHIUM BROMATUM. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.